Referencias citadas
ACOG — American College of Obstetricians and Gynecologists. (1998, July). Statement on Contraceptive Methods.
_____. (2001, April). "Medical Management of Abortion." ACOG Practice Bulletin, 26, 1-13.
_____. (2005, October). "Medical Management of Abortion." ACOG Practice Bulletin, 67, 1-12.
AGI — Alan Guttmacher Institute. (2003, accessed 2004, November). Emergency Contraception: Improving Access. [Online]. http://www.guttmacher.org/pubs/ib_3-03.html
_____. (2004). Facts in Brief: Contraceptive Use. New York: Alan Guttmacher Institute.
Aguillaume, Claude & Louise Tyrer. (1995). "Current Status and Future Projections on Use of RU-486." Contemporary Ob/Gyn, 40(6), 23-40.
Barr Pharmaceuticals, Inc. (2006, August 24). FDA Grants OTC Status to Barr's Plan B(R) Emergency Contraceptive: Historic Dual Status Decision Provides OTC Access to Those 18 Years of Age and Older; Remains Prescription for Women 17 and Younger. [Online]. http://phx.corporate-ir.net/phoenix.zhtml?c=60908&p=irol-newsArticle&ID=899120.
Breitbart, Vicki, et al. (1998). "The Impact of Patient Experience on Practice: The Acceptability of Emergency Contraceptive Pills in Inner-City Clinics." Journal of the American Medical Women's Association, 53(5 Supplement 2), 255-8.
Creinin, Mitchell & Elizabeth Aubény. (1999). "Medical Abortion in Early Pregnancy." In Maureen Paul, et al., eds, A Clinician's Guide to Medical and Surgical Abortion. New York: Churchill Livingstone.
Croxatto, Horatio B., et al. (2003). "Mechanisms of Action of Emergency Contraception." Steroids, 68, 1095-8.
DHHS — Department of Health and Human Services. (1978). Code of Federal Regulations. 45CFR46.203.
Ellertson, Charlotte, et al. (2003). "Extending the Time Limit for Starting the Yuzpe Regimen of Emergency Contraception to 120 Hours." Obstetrics & Gynecology, 101, 1168-71.
el-Refaey, H., et al. (1995). "Induction of Abortion with Mifepristone (RU 486) and Oral or Vaginal Misoprostol." New England Journal of Medicine, 332(15), 983-7.
FDA — Food and Drug Administration. (1997). "Prescription Drug Products; Certain Combined Oral Contraceptives for Use as Postcoital Emergency Contraception." Federal Register, 62(37), 8609-12.
"FDA Approves Progestin-Only Emergency Contraception." (1999). The Contraception Report, 10(5), 8-10 & 16.
Glasier, Anna & David Baird. (1998). "The Effects of Self-Administering Emergency Contraception." The New England Journal of Medicine, 339(1), 1-4.
Grimes, David A. & Mitchell D. Creinin. (2004). "Induced Abortion: An Overview for Internists." Annals of Internal Medicine, 140(8), 620-6.
Guillebaud, John. (1998). "Commentary: Time for Emergency Contraception with Levonorgestrel Alone." The Lancet, 352(9126), 416.
Harvey, S. Marie, et al. (1999). "Women's Experience and Satisfaction with Emergency Contraception." Family Planning Perspectives, 31(5), 237-40 & 260.
Hatcher, Robert A., et al. (2005). A Pocket Guide to Managing Contraception. Tiger, GA: Bridging the Gap Foundation.
Ho, Pak Chung, et al. (2002). "Mifepristone: Contraceptive and Non-Contraceptive Uses." Current Opinions in Obstetrics & Gynecology, 14(3), 325-30.
Hollander, Dore. (2000). "Most Abortion Patients View Their Experience Favorably, But Medical Abortion Gets a Higher Rating than Surgical." Family Planning Perspectives, 32(5), 264.
Hughes, Edward, ed. (1972). Obstetric-Gynecologic Terminology. Philadelphia: F. A. Davis Company.
"Make the Distinction: EC Prevents Pregnancy." (2001). Contraceptive Technology Update, 22(1), 4.
Marions, Lena, et al. (2002). "Emergency Contraception with Mifepristone and Levonorgestrel: Mechanism of Action." Obstetrics and Gynecology, 100(1), 65-71.
Middleton, Tamer, et al. (2005). "Randomized Trial of Mifepristone and Buccal or Vaginal Misoprostol for Abortion Through 56 Days of Last Menstrual Period." Contraception, 72, 328-32.
Newhall, Elizabeth Pirruccello & Beverly Winikoff. (2000). "Abortion with Mifepristone and Misoprostol: Regimens,Efficacy, Acceptability and Future Directions." American Journal of Obstetrics and Gynecology, 183(2), S44-53.
Peyron, R., et al. (1993). "Early Termination of Pregnancy with Mifepristone (RU 486) and Orally Active Prostaglandin Misoprostol." New England Journal of Medicine, 328(21), 1509-13.
PPFA — Planned Parenthood Federation of America. (2002, accessed 2004, May 20). Medical Abortion — Questions and Answers. [Online]. http://www.plannedparenthood.org/ABORTION/medicalabortion.html.
Rodrigues, Isabel, et al. (2001). "Effectiveness of Emergency Contraceptive Pills Between 72 and 120 Hours After Unprotected Sexual Intercourse." American Journal of Obstetrics and Gynecology, 184(4), 531-7.
Schaff, Eric, et al. (2000). "Low-Dose Mifepristone Followed by Vaginal Misoprostol at 48 Hours for Abortion up to 63 Days." Contraception, 61(1), 41-6.
Schaff, Eric, et al. (2001). "Randomized Trial of Oral Versus Vaginal Misoprostol at One Day After Mifepristone for Early Medical Abortion." Contraception, 64, 81-5.
Stewart, Felicia H., et al. (2005). "Abortion." Pp. 673-700 in Robert A. Hatcher, et al., eds., Contraceptive Technology, 18th Revised Edition. New York: Ardent Media, Inc.
TFPMFR — Task Force on Postovulatory Methods of Fertility Regulation. (1998). "Randomised Controlled Trial of Levonorgestrel Versus the Yuzpe Regimen of Combined Oral Contraceptives for Emergency Contraception." The Lancet, 352(9126). 428-33.
_____. (1999). "Comparison of Three Single Doses of Mifepristone as Emergency Contraception: A Randomised Trial." The Lancet, 353(9154), 697-702.
Van Look, Paul & Felicia Stewart. (1998). "Emergency Contraception." In Robert A. Hatcher et al., eds, Contraception Technology, 17th Edition. New York: Ardent Media.
von Hertzen, Helena, et al. (2002). "Low Dose Mifepristone and Two Regimens of Leonorgestrel for Emergency Contraception: A WHO Multicentre Randomised Trial." The Lancet, 360, 1803-10.
Wiebe, Ellen, et al. (2002). "Comparison of Abortions Induced by Methotrexate or Mifepristone Followed by Misoprostol." Obstetrics & Gynecology, 99(5), 813-9.
Winikoff, Beverly. (1995). "Acceptability of Medical Abortion in Early Pregnancy." Family Planning Perspectives, 27(4), 142-8 & 185, 199.
Autora principal — Jennifer Johnsen
Revisado por – Deborah Golub, MPH
Traducción — Susana Petit y Judith Cohen
Publicado: 08.24.06 | Actualizado: 08.24.06
Publicado por la Biblioteca Katharine Dexter McCormick
©2006 Planned Parenthood® Federation of America, Inc.
Todos los derechos reservados.
Contacto con los medios de comunicación
New York: 212-261-4650
Washington, DC: 202-973-4882
Contacto con la política pública
Washington, DC: 202-973-4848